Desensitization treatment of an aspirin- and mesalamine-sensitive patient with Crohn's disease [1]

Inflammatory Bowel Diseases

Volumn 11, Issue 4, 2005, Pages 417-419

  Paraskevopoulos, Ioannis ^a   Konstantinou, George ^a   Liatsos, Christos ^a  

^a KAT HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BUDESONIDE; MESALAZINE; METRONIDAZOLE; PREDNISONE;

ABDOMINAL PAIN; ADULT; ANGIONEUROTIC EDEMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DESENSITIZATION; DIARRHEA; DIZZINESS; DRUG HYPERSENSITIVITY; FACE EDEMA; FEMALE; FEVER; GENERAL CONDITION DETERIORATION; GRANULOMA; HEADACHE; HISTOLOGY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; LETTER; NAUSEA; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; SURGICAL TECHNIQUE; THORAX PAIN; URTICARIA;

EID: 17444429655     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MIB.0000164100.88404.32     Document Type: Letter

References (8)

1. Hanauer SB. Update on mesalamine for inflammatory bowel disease. Res Clin Forums. 1998; 20:203-208.
2. Hanauer SB, Meyers S. Management of Crohn's disease in adults. Am J Gastroenterol. 1997;92: 559-566.
3. Fardy JM, Lloyd DA, Reynolds RP. Adverse effects with oral 5-aminosalicylic acid. J Clin Gastroenterol. 1988;10:635-637.
4. Turunen U, Elomaa I, Anttila VJ, et al. Mesalamine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulfonamides. Scand J Gastroenterol. 1987;22:798-802.
5. Stelzle RC, Squire EN. Oral desensitization to 5-aminosalicylic acid medications. Ann Allergy Asthma Immunol. 1999;83:23-24.
6. Gonzalo MA, Alcalde MM, Garcia JM, et al. Desensitization after fever induced by mesalamine. Allergy. 1999;54:1224-1225.
7. Varela S, Diez MS, Gonzalez C, et al. Oral desensitization to 5-ASA. Allergy. 2002;57:371-372.
8. Sanchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity Ann Allergy Asthma Immunol. 2000;84:101-106.